The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 18,601–18,700 of 31,469
Role of Hexosamines in Insulin Resistance and Nutrient Sensing in Human Adipose and Muscle Tissue
Pouwels, M.-J. J., Tack, C. J., Span, P. N., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0291 · Cited by 14
Helge, J. W. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802058 · Cited by 16
Espino-Montoro, A., Barrios-Artillo, M., López‐Chozas, J. M., Cayuela, A., Stiefel, P., & Villar, J. R. (2003) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(03)80011-x · Cited by 14
Fujino, T., Ishii, Y., Takeuchi, T., Hirasawa, K., Tateda, K., Kikuchi, K., & Hasebe, N. (2003) · Circulation Journal · doi:10.1253/circj.67.757 · Cited by 15
Liangpunsakul, S., & Chalasani, N. (2004) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200411000-00012 · Cited by 14
Behavior of Insulin Resistance and Its Metabolic Correlates in Prepubertal Children
Jeffery, A., Alba, S., Murphy, M. J., Voss, L. D., Metcalf, B. S., Hosking, J., Gardner, D. S.-L., Sattar, N. A., & Wilkin, T. J. (2007) · Diabetes Care · doi:10.2337/dc07-0178 · Cited by 14
Bilateral diabetic infarction of the anterior tibial muscle.
Spengos, K., Wöhrle, J. C., Binder, J., Schwartz, A., & Hennerici, M. G. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.699a · Cited by 14
Sibutramine in the treatment of obesity in type 2 diabetic patients and in nondiabetic subjects
Tankova, T. I., Dakovska, G., Lazarova, M., Dakovska, L. N., Кirilov, G., & Koev, D. (2004) · Acta Diabetologica · doi:10.1007/s00592-004-0158-7 · Cited by 14
Murdolo, G., Lucidi, P., Loreto, C. D., Parlanti, N., Cicco, A. D., Fanelli, C. G., Perriello, G., Mughetti, D., Pippi, R., Brozzetti, A., et al. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345164 · Cited by 14
Toyoda, K., Fukushima, M., Mitsui, R., Harada, N., Suzuki, H., Takeda, T., Taniguchi, A., Nakai, Y., Kawakita, T., Yamada, Y., et al. (2008) · Metabolism · doi:10.1016/j.metabol.2007.10.002 · Cited by 14
Bard, J., Lassalle, R., Capeau, J., Bach‐Ngohou, K., Nazih‐Sanderson, F., Rémy, G., Reynes, J., Ecobichon, J.-L., Savès, M., & Raffi, F. (2006) · Antiviral Therapy · doi:10.1177/135965350601100310 · Cited by 14
Insulin Secretion in Diabetes Mellitus
Cerasi, E. (1988) · Springer eBooks · doi:10.1007/978-3-642-72691-0_11 · Cited by 14
Brismar, K. (1998) · Blood Pressure · doi:10.1080/080370598437457 · Cited by 14
Liu, X.-T., Sun, J., Li, H. Y., Zhang, L., & Qian, B. C. (2000) · PubMed · Cited by 14
Severeyn, E., Wong, S., Herrera, H., & Altuve, M. (2015) · 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2015.7319376 · Cited by 13
Esposito, K., Maiorino, M. I., Ciotola, M., Di Palo, C., Scognamiglio, P., Gicchino, M., Petrizzo, M., Saccomanno, F., Beneduce, F., Ceriello, A., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-5-200909010-00004 · Cited by 13
Schrank, Y., Fontes, R. G., Perozo, A. F. D. F., Araújo, P. B., Pinheiro, M. F. M. C., Gomes, D. M. V., & Vieira, L. M. F. (2024) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2023-0483 · Cited by 13
Martínez‐Montoro, J. I., Bandera-Merchán, B., Gutiérrez‐Bedmar, M., Gómez‐Pérez, A. M., Macías‐González, M., Moreno‐Indias, I., & Tinahones, F. J. (2025) · BMC Medicine · doi:10.1186/s12916-025-04182-z · Cited by 13
Kim, T., Oum, S.-J., Lim, J. H., Kim, Y., Kim, E. N., Jin, Y., Hong, Y. A., Chae, S. Y., Choi, B. S., Kim, H. W., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02326-5 · Cited by 13
Deng, M., Li, Z., Sun, L., Wang, H., Tang, J., Liu, Y., Chen, X., Xu, H., & Dai, Z. (2025) · Radiology · doi:10.1148/radiol.250026 · Cited by 13
Multi-omic definition of metabolic obesity through adipose tissue–microbiome interactions
Chakaroun, R., Pradhan, M., Björnson, E., Arvidsson, D., Fridolfsson, J., Gummesson, A., Schoeler, M., Mitteregger, M., Smith, G. J., Larsson, I., et al. (2026) · Nature Medicine · doi:10.1038/s41591-025-04009-7 · Cited by 22
Zhou, Z., Yang, J., Hou, J., et al. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03065-0 · Cited by 13
Joerger, M., van Schaik, R. H. N., Becker, M. L., Hayoz, S., Pollak, M., Cathomas, R. L., Winterhalder, R., Gillessen, S., & Rothermundt, C. A. (2015) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2015.8 · Cited by 13
de Luis, D. A., Ballesteros-Pomar, M. D., Guzman, A. L., Ruiz, E., Muñoz, C., Penacho, M. A., Iglesias, P., Maldonado, A., Martín, L. S., Izaola, O., et al. (2015) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12297 · Cited by 13
Ekholm, M., Kahan, T., Jörneskog, G., Brinck, J. W., & Wallén, N. H. (2015) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320315575848 · Cited by 13
Santhanam, P., Rowe, S. P., Dias, J. P., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216900 · Cited by 13
Duong, T. V., Wong, T.-C., Chen, H.-H., Chen, T.-H., Hsu, Y., Peng, S., Kuo, K., Liu, H.-C., Lin, E.-T., & Yang, S. (2019) · Nutrients · doi:10.3390/nu11061304 · Cited by 14
Fernández, A., Mazuecos, L., Pintado, C., Rubio, B., López, V., Solís, A. J. D., Rodríguez-Pérez, M., Andrés, A., & Gallardo, N. (2019) · Nutrients · doi:10.3390/nu11081865 · Cited by 13
Inoue, S., Kozuma, Y., Michio, M., Yoshizato, T., Tajiri, Y., HORI, D., & Ushijima, K. (2020) · Diabetology International · doi:10.1007/s13340-020-00425-x · Cited by 15
Ribeiro, V. B., Kogure, G. S., Silva, R. C., de Souza, H. C. D., Ferriani, R. A., & dos Reis, R. M. (2020) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0040-1701467 · Cited by 13
Hirakawa, Y., Hata, J., Yoshinari, M., Higashioka, M., Yoshida, D., Shibata, M., Honda, T., Sakata, S., Kato, H., Teramoto, T., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001156 · Cited by 14
Bergia, R. E., Biskup, I., Giacco, R., Costabile, G., Gray, S., Wright, A. J., Vitale, M., Campbell, W. W., Landberg, R., & Riccardi, G. (2020) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2020.100640 · Cited by 13
Ratajczak, M., Skrypnik, D., Krutki, P., & Karolkiewicz, J. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17238718 · Cited by 15
Agrawal, K., Mathur, R., Purwar, N., Mathur, S., & Mathur, D. (2021) · Dermatology · doi:10.1159/000512918 · Cited by 11
Pablo, S., Rodríguez‐Comas, J., Díaz-Catalán, D., Alcarraz‐Vizán, G., Castaño, C., Moreno‐Vedia, J., Montané, J., Párrizas, M., Servitja, J., & Novials, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-91311-2 · Cited by 13
Metabolic Evaluation in Patients With Hepatitis C Treated With Direct Antiviral Agents
Estefan, S., Brandão‐Mello, C. E., Silva, C. M. D. S., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.631600 · Cited by 13
Jakubowski, K., Barinas‐Mitchell, E., Chang, Y., Maki, P. M., Matthews, K. A., & Thurston, R. C. (2021) · Annals of Behavioral Medicine · doi:10.1093/abm/kaab046 · Cited by 17
Sekine, T., Takizawa, S., Uchimura, K., Miyazaki, A., & Tsuchiya, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158314 · Cited by 13
Hepatogenous Diabetes - A Report from Central India
Vasepalli, P., Noor, M. T., & Thakur, B. S. (2021) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2021.08.018 · Cited by 14
Khoudary, S. R. E., Qi, M., Chen, X., Matthews, K. A., Allshouse, A. A., Crawford, S. L., Derby, C. A., Thurston, R. C., Kazlauskaite, R., Barinas‐Mitchell, E., et al. (2021) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001876 · Cited by 13
Chen, Y., Qiu, C., Yu, W., Shao, X., Zhou, M., Wang, Y., & Shao, X. (2021) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001511 · Cited by 13
Association of sleep quality with insulin resistance in obese or overweight subjects
Hashemipour, S., Ghorbani, A., Khashayar, A., & Olfati, H. (2021) · Sleep Science · doi:10.5935/1984-0063.20200084 · Cited by 13
A meal enriched in saturated fat acutely impairs cognitive performance in obese men
Ruegsegger, G. N., Rappaport, C. I., Hill, J. J., Jochum, K. A., Challeen, E. S., & Roth, M. C. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113664 · Cited by 13
Grangeiro, É. D., Trigueiro, M. S., Siais, L. D. O., Paiva, H. M., Sola‐Penna, M., Alves, M. R., & Rosado, E. L. (2021) · Food & Function · doi:10.1039/d1fo00484k · Cited by 13
Metzing, U. B., von Loeffelholz, C., Steidl, R., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-04517-9 · Cited by 13
Mengel, L. A., Moud, B. N., Seidl, H., Mesas‐Fernández, A., Seeliger, C., Brandl, B., Skurk, T., Holzapfel, C., Claussnitzer, M., & Hauner, H. (2022) · Obesity Facts · doi:10.1159/000522218 · Cited by 13
Dietary Intakes of Animal and Plant Proteins and Risk of Colorectal Cancer: The EPIC-Italy Cohort
Sieri, S., Agnoli, C., Pala, V. M., Grioni, S., Palli, D., Bendinelli, B., Macciotta, A., Ricceri, F., Panico, S., de Magistris, M. S., et al. (2022) · Cancers · doi:10.3390/cancers14122917 · Cited by 16
Scovronec, A., Provencher, A., Iceta, S., Pelletier, M., Leblanc, V., Nadeau, M., Simard, S., Biertho, L. D., Richard, D., Tchernof, A., et al. (2022) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2022.07.005 · Cited by 13
Idowu, O. K., Oluyomi, O. O., Faniyan, O. O., Dosumu, O. O., & Akinola, O. B. (2022) · Ibrain · doi:10.1002/ibra.12059 · Cited by 12
Genovesi, S., Montelisciani, L., Viazzi, F., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.978366 · Cited by 13
Saphyakhajorn, W., Sirirat, R., & Sapwarobol, S. (2022) · BMC Nutrition · doi:10.1186/s40795-022-00586-9 · Cited by 13
Damas-Fuentes, M., Boughanem, H., Molina‐Vega, M., Tinahones, F. J., Fernández‐García, J. C., & Macías‐González, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.960222 · Cited by 15
Data Mining Framework for Discovering and Clustering Phenotypes of Atypical Diabetes
Parikh, H. M., Remedios, C. L., Hampe, C. S., Balasubramanyam, A., Fisher‐Hoch, S. P., Choi, Y. J., Patel, S. G., McCormick, J. B., REDONDO, M. J., & Krischer, J. P. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac632 · Cited by 13
Hazman, Ö., Bozkurt, M. F., Kumral, Z. B., et al. (2022) · Biologia · doi:10.1007/s11756-022-01266-6 · Cited by 13
Palacio, T. L. N., Siqueira, J. S., de Paula, B. H., Rego, R. M. P., Vieira, T. A., Baron, G., Altomare, A., Ferron, A. J. T., Aldini, G., Kano, H. T., et al. (2022) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2022.2154328 · Cited by 14
Blüher, M., Malhotra, A., & Bader, G. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14969 · Cited by 14
Tripolt, N. J., Hofer, S. J., Pferschy, P. N., Aziz, F., Durand, S., Aprahamian, F., Nirmalathasan, N., Waltenstorfer, M., Eisenberg, T., Obermayer, A. M., et al. (2023) · Nutrients · doi:10.3390/nu15030511 · Cited by 16
Hasegawa, Y., Pei, R., Raghuvanshi, R., et al. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.01.021 · Cited by 13
Carotid intima media thickness and white matter hyperintensity volume among midlife women
Thurston, R. C., Wu, M., Barinas‐Mitchell, E., Chang, Y., Aizenstein, H. J., Derby, C. A., & Maki, P. M. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12951 · Cited by 13
Predictors of treatment response to serotonin and noradrenaline reuptake inhibitors in fibromyalgia
Krupa, A. J., Korkosz, M., Gorostowicz, A., Nowakowski, J., Kierzkowska, I., Dudek, D., & Siwek, M. (2023) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16432 · Cited by 13
Kuker, A. P., Shen, W., Jin, Z., Chen, J., Bruce, J. N., & Freda, P. U. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad028 · Cited by 12
Cho, Y., Chang, Y., Ryu, S., Kim, C., Wild, S. H., & Byrne, C. D. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002250 · Cited by 15
Buckland, G., Taylor, C. M., Emmett, P. M., et al. (2023) · British Journal Of Nutrition · doi:10.1017/s0007114523000685 · Cited by 13
Fogacci, F., Giovannini, M., Imbalzano, E., Grandi, E., Rizzoli, E., D’Addato, S., & Cicero, A. F. G. (2023) · Archives of Medical Science · doi:10.5114/aoms/163368 · Cited by 13
Uric acid level in climacteric women and its association with clinical and metabolic parameters
Souza, L. A. C. E., D’Angelo, G. C. D. O., da Silva, G. N., & Lima, A. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-35287-1 · Cited by 14
Fryk, E., Silva, V. R. R., Bauzá-Thorbrügge, M., Schmelz, M., Gan, L., Strindberg, L., & Jansson, P. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101985 · Cited by 13
Osuna‐Prieto, F. J., Xu, H., Ortiz-Alvarez, L., Di, X., Köhler, I., Jurado‐Fasoli, L., Rubio‐López, J., Plaza‐Díaz, J., Vilchez‐Vargas, R., Link, A., et al. (2023) · Metabolomics · doi:10.1007/s11306-023-02016-8 · Cited by 14
Gender, Obesity, Fat Distribution and 25-Hydroxyvitamin D
Guagnano, M. T., D’Ardes, D., Giovanni, P. D., Rossi, I., Boccatonda, A., Bucci, M., & Cipollone, F. (2023) · Medicina · doi:10.3390/medicina59061123 · Cited by 14
Rohmann, N., Stürmer, P., Geisler, C., Schlicht, K., Knappe, C., Hartmann, K., Türk, K., Hollstein, T., Beckmann, A., Seoudy, A. K., et al. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.06.005 · Cited by 14
Nikrad, N., Shakarami, A., Tousi, A. Z., Farhangi, M. A., Ardekani, A. M., & Jafarzadeh, F. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01392-5 · Cited by 13
Combination of Pioglitazone and Metformin Actions on Liver Lipid Metabolism in Obese Mice
Liu, J. Y., Wang, D., Xie, Z., Ding, L., Li, S., Ma, X.-M., Liu, J., Ren, J., Xiao, C., Yang, C., et al. (2023) · Biomolecules · doi:10.3390/biom13081199 · Cited by 14
Mund, C., Kellellu, C. K., Rattan, R., Mahapatra, S., Lamare, A. A., & Jena, S. (2023) · Cureus · doi:10.7759/cureus.43401 · Cited by 13
Moreno‐Cabañas, A., Morales‐Palomo, F., Álvarez-Jiménez, L., Mora‐Gonzalez, D., ORTEGA, J. F., & Mora‐Rodríguez, R. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00118.2023 · Cited by 14
Wilson, S. M. G., Peach, J. T., Fausset, H., Miller, Z. J., Walk, S. T., Yeoman, C. J., Bothner, B. B., & Miles, M. P. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1244692 · Cited by 16
Duo, Y., Song, S., Zhang, Y., Qiao, X., Xu, J., Zhang, J., Peng, Z., Chen, Y., Nie, X., Sun, Q., et al. (2023) · Endocrine · doi:10.1007/s12020-023-03544-y · Cited by 13
Ramírez‐Manent, J. I., López‐González, Á. A., Tomás-Gil, P., Sbert, P. R., Garrido-Sepulveda, L., & Vicente-Herrero, M. T. (2023) · Diagnostics · doi:10.3390/diagnostics13213356 · Cited by 15
de Medeiros, S. F., de Medeiros, A. K. L. W. Y., de Medeiros, M. A. S., Carvalho, A. B. D. S., Yamamoto, M. M., Soares, J. M., & Baracat, E. C. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2207-0739 · Cited by 14
Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01229-0 · Cited by 15
Zhang, L., Wang, H., Zu, P., Li, X., Ma, S., Zhu, Y., Xie, T., Tao, F., Zhu, D.-M., & Zhu, P. (2024) · Environmental Research · doi:10.1016/j.envres.2024.118178 · Cited by 14
Park, Y.-H., Sohn, M., Lee, S. Y., & Lim, S. K. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0128 · Cited by 14
Cui, J., Liu, Y., Li, M., et al. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01560-1 · Cited by 13
Desjardins, L.-C., Brière, F., Tremblay, A. J., Rancourt-Bouchard, M., Drouin‐Chartier, J., Corbeil, J., Lemelin, V., Charest, A., Schaefer, E. J., Lamarche, B., et al. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.03.015 · Cited by 15
Long-term pasireotide therapy in acromegaly: extensive real-life experience of a referral center
Pirchio, R., Auriemma, R., Vergura, A., Pivonello, R., & Colao, A. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02299-7 · Cited by 8
Li, K., Yang, Y., Zhao, J., Zhou, Q., Li, Y., Yang, M., Hu, Y., Xu, J., Zhao, M., & Xu, Q. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.134224 · Cited by 14
Baudin, J., Hernández-Baixauli, J., Quesada‐Vázquez, S., Mulero, F., Puiggròs, F., Arola, L., & Caimari, A. (2024) · Food & Function · doi:10.1039/d3fo05122f · Cited by 13
Inflammatory, metabolic, and endothelial biomarkers before and after pregnancy complications
Sun, B., Gunderson, E. P., Bertolet, M. H., Lopa, S., Bryan, S. D., Lewis, C. E., & Catov, J. M. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae053 · Cited by 13
Spaur, M., Gálvez-Fernández, M., Chen, Q., Lombard, M. A., Bostick, B. C., Factor-Litvak, P. R., Fretts, A. M., Shea, S., Navas‐Acién, A., & Nigra, A. E. (2024) · Diabetes Care · doi:10.2337/dc23-2231 · Cited by 14
Effects of intermittent fasting on periodontal inflammation and subgingival microbiota
Lira‐Junior, R., Aogáin, M. M., Crncalo, E., Ekberg, N. R., Chotirmall, S. H., Pettersson, S., Gustafsson, A. K., Brismar, K., & Bostancı, N. (2024) · Journal of Periodontology · doi:10.1002/jper.23-0676 · Cited by 16
Moon, J. H., Choe, H. J., & Lim, S. K. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14221 · Cited by 13
Childhood adversity, accelerated GrimAge, and associated health consequences
Harvanek, Z. M., Kudinova, A. Y., Wong, S., Xu, K., Brick, L. A. D., Daniels, T. E., Marsit, C. J., Burt, A., Sinha, R., & Tyrka, A. R. (2024) · Journal of Behavioral Medicine · doi:10.1007/s10865-024-00496-0 · Cited by 18
Zhuang, J., Wang, S., Wang, Y., et al. (2024) · International Journal of Women s Health · doi:10.2147/ijwh.s461950 · Cited by 13
Long‐term efficacy of washed microbiota transplantation in overweight patients
Lin, D., Hu, D., Song, Y., He, X., & Wu, L. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14260 · Cited by 14
Kwok, T. C., Ramage, L. E., Kelman, A., Suchacki, K. J., Gray, C. D., Boyle, L. D., Semple, S. I. K., MacGillivray, T., Macnaught, G., Patel, D., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae074 · Cited by 15
Mohamed, N. A., Ithmil, M. T., Elkady, A. I., & Salam, S. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136922 · Cited by 17
Cisternas, C., Farías, C., Valenzuela, R., Bravo, H., Paz, A. V. C., Alejandra, E., & Muñoz, L. A. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106329 · Cited by 14
Chikwati, R. P., Jaff, N. G., Mahyoodeen, N. G., Micklesfield, L. K., Ramsay, M., Gómez-Olivé, F. X., Mohamed, S. F., Choma, S. S. R., George, J. A., & Crowther, N. J. (2024) · Maturitas · doi:10.1016/j.maturitas.2024.108069 · Cited by 12
Fraiz, G. M., Costa, M. A. D. C., Cardoso, R. R., Hébert, J. R., Zhao, L., Corich, V., Giacomini, A., Milagro, F. I., de Barros, F. A. R., & Bressan, J. (2024) · Fermentation · doi:10.3390/fermentation10080384 · Cited by 16
He, Y., Gao, M., Hu, M., Ban, Y., Li, Z., Hu, S., Cao, S., Deng, L., Xiao, S., & Xie, X. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02259-x · Cited by 13
Gruber, J., Ruf, A., Süß, E. D., Tariverdian, S., Ahrens, K. F., Schiweck, C., Ebner‐Priemer, U., Thanarajah, S. E., Reif, A., & Matura, S. (2024) · Nutrition and Diabetes · doi:10.1038/s41387-024-00331-0 · Cited by 19
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
